| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.0M | — |
| SG&A Expense | $286K | +72.1% |
| Interest Expense | $556K | +14.2% |
| Pre-tax Income | -$16.5M | -109.2% |
| Income Tax | $0 | — |
| Net Income | -$16.5M | -109.2% |
| EPS (Basic) | -$0.76 | -65.2% |
| EPS (Diluted) | -$0.76 | -65.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | -35.0% |
| Short-term Investments | $15.3M | +1417.5% |
| Current Assets | $20.1M | +141.2% |
| Total Assets | $28.4M | +175.6% |
| Current Liabilities | $3.1M | -81.0% |
| Total Liabilities | $3.5M | -78.5% |
| Stockholders' Equity | $24.9M | +522.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.2M | -112.9% |
| Capital Expenditures | $151K | — |
| Investing Cash Flow | -$20.3M | -1515.7% |
| Financing Cash Flow | $26.1M | +147.5% |
| Free Cash Flow | -$8.4M | -116.8% |